Boston Scientific (BSX) said Monday it has entered into a definitive agreement to acquire privately held Valencia Technologies.
The acquisition will expand the company's urology offerings, Boston Scientific said.
The transaction, expected to be completed within H1, will have no material impact on 2026 adjusted earnings per share, the company said.
Financial terms were not provided.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments